Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

AlgiPharma AS - Product Pipeline Review - 2015

147 Aufrufe

Veröffentlicht am

This report provides comprehensive information on the current therapeutic developmental pipeline of AlgiPharma ASs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of AlgiPharma AS including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of AlgiPharma ASs human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the AlgiPharma ASs pipeline products

Reasons to buy

Evaluate AlgiPharma ASs strategic position with total access to detailed information on its product pipeline
Assess the growth potential of AlgiPharma AS in its therapy areas of focus
Identify new drug targets and therapeutic classes in the AlgiPharma ASs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of AlgiPharma AS and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain c

Veröffentlicht in: Business
  • Als Erste(r) kommentieren

  • Gehören Sie zu den Ersten, denen das gefällt!

AlgiPharma AS - Product Pipeline Review - 2015

  1. 1. AlgiPharma AS - Product Pipeline Review - 2015 Global Markets Directs, AlgiPharma AS Product Pipeline Review 2015, provides an overview of the AlgiPharma ASs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of AlgiPharma ASs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides brief overview of AlgiPharma AS including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of AlgiPharma ASs human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AlgiPharma ASs pipeline products Reasons to buy Evaluate AlgiPharma ASs strategic position with total access to detailed information on its product pipeline Assess the growth potential of AlgiPharma AS in its therapy areas of focus Identify new drug targets and therapeutic classes in the AlgiPharma ASs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of AlgiPharma AS and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of AlgiPharma AS Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of AlgiPharma AS and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues table Of Contents table Of Contents 2 list Of Tables 3 list Of Figures 3 algipharma As Snapshot 4 algipharma As Overview 4 key Information 4 key Facts 4 algipharma As - Research And Development Overview 5 key Therapeutic Areas 5 algipharma As - Pipeline Review 7 pipeline Products By Stage Of Development 7 pipeline Products - Monotherapy 8 algipharma As - Pipeline Products Glance 9 algipharma As - Clinical Stage Pipeline Products 9 phase Ii Products/combination Treatment Modalities 9 phase I Products/combination Treatment Modalities 10 algipharma As - Early Stage Pipeline Products 11 preclinical Products/combination Treatment Modalities 11 algipharma As - Unknown Stage Pipeline Products 12 unknown Products/combination Treatment Modalities 12 algipharma As - Drug Profiles 13 oligomer G For Cystic Fibrosis 13 product Description 13 mechanism Of Action 13 r&d Progress 13 oligomer G For Copd 15 product Description 15 mechanism Of Action 15 r&d Progress 15 oligomer G For Wounds And Burns 16 product Description 16 mechanism Of Action 16 r&d Progress 16 AlgiPharma AS - Product Pipeline Review - 2015
  2. 2. oligomer G For Pseudomonas Aeruginosa Infectious 17 product Description 17 mechanism Of Action 17 r&d Progress 17 algipharma As - Pipeline Analysis 18 algipharma As - Pipeline Products By Route Of Administration 18 algipharma As - Pipeline Products By Molecule Type 19 algipharma As - Recent Pipeline Updates 20 algipharma As - Locations And Subsidiaries 21 head Office 21 appendix 22 methodology 22 coverage 22 secondary Research 22 primary Research 22 expert Panel Validation 22 contact Us 22 disclaimer 23 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: Sales Team, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ AlgiPharma AS - Product Pipeline Review - 2015

×